Humana Inc. (NYSE:HUM) saw an upside of 1.34% to close Tuesday at $420.42 after adding $5.55 on the day. The 5-day average trading volume is 892,500 shares of the company’s common stock. It has gained $422.03 in the past week. An average of 760,145 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 751,886.
HUM’s 1-month performance is 2.78% or $18.44 on its low of $381.86 reached on 10/06/21. The company’s shares have touched a 52-week low of $370.22 and high of $475.44, with the stock’s rally to the 52-week high happening on 05/10/21. YTD, HUM has achieved 2.47% or $10.15. However, the current price is down -11.57%% from the 52-week high price.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
On Sep 16, 27 days have gone by since the last insider trading activity for Humana Inc. (HUM). JONES DAVID A JR/KY (Director) most recently sold 4,800 shares at $401.00 per share on Sep 16. This transaction cost the insider $1,924,800. Seg Pres, Clin & Phm Solutions, Fleming William Kevin, sold 8,899 shares at a price of $459.29 on May 04. Then, on May 03, Segment President, Retail Wheatley Timothy Alan sold 8,508 shares at a price of $450.59 per share. This transaction amounted to $3,833,609.
The company’s PE ratio for the last five years has touched a high of 54.27 and a low of 10.68. HUM stock has a beta of 0.88. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 0.66 while the price-to-book (PB) in the most recent quarter is 3.65, with the price to cash flow ratio at 455.68.
Humana Inc. pays an annual dividend of $2.80 per share. Its dividend yield is 0.67% and the payout ratio is 13.90%. HUM paid $0.70 a share compared with prior rate of $0.70, down 0.0% from last year’s. The company has boosted its dividend for the last 1 consecutive years with the latest dividend increase of $0.0750 reported on Thursday February 18 2021. Measured over the last 3 years, the Dividend has been growing by 32.28% yearly.
It is projected that Humana Inc.’s next ex-dividend date will be on 30-Dec. HUM is expected to distribute $0.70 as its next dividend.
As well, the company’s long term debt to equity for the quarter ending June 29 was 0.41, while the total debt to equity was 0.50 while for the period ending June 29; Humana Inc.’s operating margin was 4.90%. The firm’s gross profit as reported stood at $15.53 billion against revenue of $77.16 billion.
For the quarterly period ending June 29 this year, Net income and sales went down compared to those figures reported in the previous quarter. Analysts expected HUM to announce $6.82 per share in earnings in its latest quarter, but it posted $6.89, representing a 1.00% surprise. EBITDA for the quarter stood at more than $1.41 billion. HUM stock balance sheet for the quarter ending June 29 shows that total liabilities totaled 23.23 billion, with total debt at $7.41 billion. Shareholders hold equity totaling $128.5 million
Let’s look briefly at Humana Inc. (HUM) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 12 October was 72.22% to suggest the stock is trending Overbought, with historical volatility in this time period at 21.99%.
The stock’s 5-day moving average is $408.88, reflecting a +8.27% or $32.11 change from its current price. HUM is currently trading +4.58% above its 20-day SMA, -4.40% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 and SMA200 by -2.13% and +3.85% respectively.
Stochastic %K and %D was 96.70% and 87.72% and the average true range (ATR) pointed at 8.93. The RSI (14) points at 63.68%, while the 14-day stochastic is at 95.99% with the period’s ATR at 8.67. The stock’s 9-day MACD Oscillator is pointing at 16.20 and 16.72 on the 14-day charts.
In the most recent analyst report for Humana Inc. (NYSE: HUM), SVB Leerink launched coverage with an Outperform rating. Analysts offering their rating for HUM stock have a consensus rating for the stock as Overweight. Currently, 0 brokerage advisors rate HUM as a “sell,”, while 9 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 0 rates the stock as overweight while 17 have offered a “buy” rating.
What is HUM’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $427.00 and a high of $525.00, with their median price target at $496.00. Looking at these predictions, the average price target given by analysts is for Humana Inc. (HUM) stock is $491.59.